Hemochromatosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(26 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hemochromatosis]] | |||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MJ}} | ||
==Overview== | ==Overview== | ||
Haemochromatosis | Haemochromatosis should be differentiate from other disorders with [[iron]] overload. Iron overload can be sue to [[iron]] absorption, or [[iron]] overload. Diseases in this category are: hemochromatosis, [[Thalassemia]], [[chronic liver disease]], [[sideroblastic anemia]], [[african iron overload]], and transfusion iron overload. | ||
==Differentiating Hemochromatosis from other Diseases== | ==Differentiating Hemochromatosis from other Diseases== | ||
Haemochromatosis should be differentiate from other disorders with [[iron]] overload. Iron overload can be sue to [[iron]] absorption, or [[iron]] overload. Diseases in this category are: hemochromatosis, [[Thalassemia]], [[chronic liver disease]], [[sideroblastic anemia]], [[african iron overload]], and transfusion iron overload. | |||
* '''[[ | |||
{| class="wikitable" align="center" style="border: 0px; font-size: 90%; margin: 3px;" | |||
* ''' | |+Different causes of iron overload | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disorder | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory abnormalities | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical examination | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | |||
|- | |||
| rowspan="5" align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Increased Iron absorption''' | |||
|'''Hemochromatosis'''<ref>[http://digestive.niddk.nih.gov/ddiseases/pubs/hemochromatosis/index.htm Hemochromatosis-Diagnosis] National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services</ref><ref name="pmid234187622">{{cite journal| author=Crownover BK, Covey CJ| title=Hereditary hemochromatosis. | journal=Am Fam Physician | year= 2013 | volume= 87 | issue= 3 | pages= 183-90 | pmid=23418762 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23418762 }}</ref><ref name="Nielsen_1995">{{cite journal |author=Nielsen J, Jensen L, Krabbe K |title=Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome |journal=J Neurol Neurosurg Psychiatry |volume=59 |issue=3 |pages=318-21 |year=1995 |pmid=7673967}}</ref><ref name="Costello_2004">{{cite journal |author=Costello D, Walsh S, Harrington H, Walsh C |title=Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series |journal=J Neurol Neurosurg Psychiatry |volume=75 |issue=4 |pages=631-3 |year=2004 |pmid=15026513}}</ref><ref name="pmid25454304">{{cite journal| author=Salgia RJ, Brown K| title=Diagnosis and management of hereditary hemochromatosis. | journal=Clin Liver Dis | year= 2015 | volume= 19 | issue= 1 | pages= 187-98 | pmid=25454304 | doi=10.1016/j.cld.2014.09.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25454304 }}</ref> | |||
| | |||
* Mutated [[HFE (gene)|HFE gene]] | |||
| | |||
* Increased [[ferritin]] levels | |||
* Decreased [[total iron-binding capacity]] | |||
* High serum Iron | |||
* High [[transferrin saturation]] | |||
* High Hepatic iron concentration μg/g dry weight | |||
* Perls' Prussian blue stain positive for Iron | |||
* High Hepatic iron index | |||
| | |||
*[[Fatigue]] | |||
*Weakness | |||
*Weight loss | |||
*[[Abdominal pain]] | |||
*[[Joint pain]] | |||
*Congestive [[heart failure]], [[arrhythmia]]s or [[pericarditis]] | |||
*[[Deafness]] | |||
*Dysfunction of certain [[endocrine organs]]: | |||
**[[Pancreas|Pancreatic gland]], as above, manifesting as [[diabetes]] | |||
**[[Adrenal gland]] (leading to [[adrenal insufficiency]]) | |||
**[[Parathyroid gland]] (leading to [[hypocalcaemia]]) | |||
**[[Pituitary gland]] | |||
**[[Testes]] or [[ovary]] (leading to [[hypogonadism]]) | |||
*A darkish color to the skin (see pigmentation, hence its name '''''Diabete bronze''''' ) | |||
* | |||
| | |||
* [[Genetic mutations]] that affects [[iron]] absorption | |||
|- | |||
|'''[[Thalassemia]]<ref name="pmid23028133">{{cite journal| author=Gibbons RJ| title=α-Thalassemia, mental retardation, and myelodysplastic syndrome. | journal=Cold Spring Harb Perspect Med | year= 2012 | volume= 2 | issue= 10 | pages= | pmid=23028133 | doi=10.1101/cshperspect.a011759 | pmc=3475406 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23028133 }}</ref>''' | |||
| | |||
*[[Genetic defect]] with alpha- or [[beta-globin]] production | |||
*Absence of alpha or beta-globin chains | |||
| | |||
*Abnormal [[hemoglobin]] [[electrophoresis]] | |||
*Abnormal [[high performance liquid chromatography]]<ref name="pmid16461765">{{cite journal| author=Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH| title=Screening and counseling for thalassemia. | journal=Blood | year= 2006 | volume= 107 | issue= 4 | pages= 1735-7 | pmid=16461765 | doi=10.1182/blood-2005-09-3557 | pmc=1895412 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16461765 }}</ref> | |||
*Elevated ferritin (due to frequent transfusions and iron overload) | |||
*Microcytic hypochromic anemia | |||
| | |||
*[[Irritability]] | |||
*[[Growth retardation]] | |||
*[[Jaundice]] | |||
*[[Hepatomegaly]] | |||
*[[Splenomegaly]] | |||
| | |||
* Ineffective [[erythropoiesis]] leading to suppression of [[hepcidin]] | |||
* Transfusional [[iron]] overload may also contribute | |||
|- | |||
|'''[[Chronic liver disease]]<ref name="pmid25548474">{{cite journal |vauthors=Ceni E, Mello T, Galli A |title=Pathogenesis of alcoholic liver disease: role of oxidative metabolism |journal=World J. Gastroenterol. |volume=20 |issue=47 |pages=17756–72 |year=2014 |pmid=25548474 |pmc=4273126 |doi=10.3748/wjg.v20.i47.17756 |url=}}</ref><ref name="pmid25920088">{{cite journal |vauthors=Mathurin P, Bataller R |title=Trends in the management and burden of alcoholic liver disease |journal=J. Hepatol. |volume=62 |issue=1 Suppl |pages=S38–46 |year=2015 |pmid=25920088 |pmc=5013530 |doi=10.1016/j.jhep.2015.03.006 |url=}}</ref><ref name="pmid19553649">{{cite journal |vauthors=Lucey MR, Mathurin P, Morgan TR |title=Alcoholic hepatitis |journal=N. Engl. J. Med. |volume=360 |issue=26 |pages=2758–69 |year=2009 |pmid=19553649 |doi=10.1056/NEJMra0805786 |url=}}</ref><ref name="pmid27834478">{{cite journal |vauthors=Datz C, Müller E, Aigner E |title=Iron overload and non-alcoholic fatty liver disease |journal=Minerva Endocrinol. |volume=42 |issue=2 |pages=173–183 |date=June 2017 |pmid=27834478 |doi=10.23736/S0391-1977.16.02565-7 |url=}}</ref>''' | |||
| | |||
* [[Alcoholic liver disease]] | |||
* [[Chronic hepatitis]] | |||
* [[Non-alcoholic fatty liver disease|Non-alcoholic fatty liver disease (NAFLD)]] | |||
| | |||
* Impaired [[liver]] function tests with hepatocellular pattern | |||
* High [[ferritin]] | |||
| | |||
* [[Jaundice]] | |||
* [[Gynecomastia]] | |||
* [[Spider angiomata]] | |||
* [[Bruising]] | |||
* [[Hepatosplenomegaly]] | |||
* [[Ascites]] | |||
* [[Testicular atrophy]] | |||
* [[Asterixis]] | |||
* [[Palmar erythema]] | |||
| | |||
* Reduced [[hepcidin]] production | |||
|- | |||
|'''[[Sideroblastic anemia]]<ref name="pmid21632840">{{cite journal |vauthors=Cazzola M, Invernizzi R |title=Ring sideroblasts and sideroblastic anemias |journal=Haematologica |volume=96 |issue=6 |pages=789–92 |date=June 2011 |pmid=21632840 |pmc=3105636 |doi=10.3324/haematol.2011.044628 |url=}}</ref><ref name="pmid25064706">{{cite journal |vauthors=Bottomley SS, Fleming MD |title=Sideroblastic anemia: diagnosis and management |journal=Hematol. Oncol. Clin. North Am. |volume=28 |issue=4 |pages=653–70, v |date=August 2014 |pmid=25064706 |doi=10.1016/j.hoc.2014.04.008 |url=}}</ref><ref name="pmid29787825">{{cite journal |vauthors=Long Z, Li H, Du Y, Han B |title=Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology |journal=Gene |volume=668 |issue= |pages=182–189 |date=August 2018 |pmid=29787825 |doi=10.1016/j.gene.2018.05.074 |url=}}</ref>''' | |||
| | |||
* [[Alcoholism]] | |||
* [[Chloramphenicol]] | |||
* [[Isoniazid]] | |||
* [[Copper deficiency]] (nutritional, [[zinc]]-induced, copper chelation) | |||
* Vit B-6 deficiency | |||
* X-linked sideroblastic anemia | |||
| | |||
* Microcytic hypochromic [[anemia]] | |||
* Normal to low reticulocyte count | |||
* Increased [[ferritin]] levels | |||
* Decreased [[total iron-binding capacity]] | |||
* [[Hematocrit]], 20-30% | |||
* High serum Iron | |||
* High [[transferrin saturation]] | |||
* Basophilic stippling of red blood cells on peripheral blood smear in [[lead poisoning]] | |||
* Prussian Blue stain of RBC in marrow, shows ringed sideroblasts | |||
| | |||
*[[Seborrheic dermatitis]] | |||
*Glossy Tongue | |||
*[[Tingling]] | |||
* Patient present with symptoms of [[Vitamin B6]], [[copper deficiency]] symptoms | |||
| | |||
* Ineffective [[erythropoiesis]] leading to suppression of [[hepcidin]] | |||
* Increased [[iron]] recycling from the [[bone marrow]] and accumulation in the liver. | |||
|- | |||
|'''[[African iron overload]]<ref name="pmid12382201">{{cite journal |vauthors=Gordeuk VR |title=African iron overload |journal=Semin. Hematol. |volume=39 |issue=4 |pages=263–9 |date=October 2002 |pmid=12382201 |doi= |url=}}</ref><ref name="Gordeuk_2003">{{cite journal |author=Gordeuk V, Caleffi A, Corradini E, Ferrara F, Jones R, Castro O, Onyekwere O, Kittles R, Pignatti E, Montosi G, Garuti C, Gangaidzo I, Gomo Z, Moyo V, Rouault T, MacPhail P, Pietrangelo A |title=Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene |journal=Blood Cells Mol Dis |volume=31 |issue=3 |pages=299-304 |year=2003 |pmid=14636642}}</ref>''' | |||
| | |||
* Gene [[polymorphism (biology)|polymorphism]] in the gene for [[ferroportin]] which predisposes some people of African descent to iron overload | |||
| | |||
* Increased [[ferritin]] levels | |||
* Decreased [[total iron-binding capacity]] | |||
* High serum Iron | |||
* High [[transferrin saturation]] | |||
|Insert paragraph | |||
* [[Fatigue]] | |||
* Weakness | |||
* Weight loss | |||
* [[Abdominal pain]] | |||
* [[Joint pain]] | |||
* Congestive [[heart failure]] | |||
* Dysfunction of certain [[endocrine organs]] | |||
|Increase [[iron]] absorption from intestine | |||
|- | |||
| rowspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |'''Increased Iron intake''' | |||
|[[Transfusional iron overload|'''Transfusional overload''']] | |||
| | |||
* Recurrent blood transfusion for any reason | |||
| | |||
* Increased [[ferritin]] levels | |||
* Decreased [[total iron-binding capacity]] | |||
* High serum Iron | |||
* High [[transferrin saturation]] | |||
| | |||
*[[Fatigue]] | |||
*Weakness | |||
*Weight loss | |||
*[[Abdominal pain]] | |||
*[[Joint pain]] | |||
*Congestive [[heart failure]] | |||
*Dysfunction of certain [[endocrine organs]] | |||
| | |||
* Extra [[iron]] infusion | |||
|- | |||
|'''[[Hemin]] infusion''' | |||
* Treat [[acute intermittent porphyria]] | |||
| | |||
* [[Hemin]] infusion | |||
| | |||
* Increased [[ferritin]] levels | |||
* Decreased [[total iron-binding capacity]] | |||
* High serum Iron | |||
* High [[transferrin saturation]] | |||
| | |||
*[[Fatigue]] | |||
*Weakness | |||
*Weight loss | |||
*[[Abdominal pain]] | |||
*[[Joint pain]] | |||
*Congestive [[heart failure]] | |||
*Dysfunction of certain [[endocrine organs]] | |||
| | |||
* Extra [[iron]] infusion | |||
|} | |||
==References== | ==References== |
Latest revision as of 22:10, 8 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Haemochromatosis should be differentiate from other disorders with iron overload. Iron overload can be sue to iron absorption, or iron overload. Diseases in this category are: hemochromatosis, Thalassemia, chronic liver disease, sideroblastic anemia, african iron overload, and transfusion iron overload.
Differentiating Hemochromatosis from other Diseases
Haemochromatosis should be differentiate from other disorders with iron overload. Iron overload can be sue to iron absorption, or iron overload. Diseases in this category are: hemochromatosis, Thalassemia, chronic liver disease, sideroblastic anemia, african iron overload, and transfusion iron overload.
Category | Disorder | Etiology | Laboratory abnormalities | Physical examination | Mechanism |
---|---|---|---|---|---|
Increased Iron absorption | Hemochromatosis[1][2][3][4][5] |
|
|
|
|
Thalassemia[6] |
|
|
| ||
Chronic liver disease[8][9][10][11] |
| ||||
Sideroblastic anemia[12][13][14] |
|
|
|
| |
African iron overload[15][16] |
|
|
Insert paragraph
|
Increase iron absorption from intestine | |
Increased Iron intake | Transfusional overload |
|
|
|
|
Hemin infusion |
|
|
|
|
References
- ↑ Hemochromatosis-Diagnosis National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
- ↑ Crownover BK, Covey CJ (2013). "Hereditary hemochromatosis". Am Fam Physician. 87 (3): 183–90. PMID 23418762.
- ↑ Nielsen J, Jensen L, Krabbe K (1995). "Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome". J Neurol Neurosurg Psychiatry. 59 (3): 318–21. PMID 7673967.
- ↑ Costello D, Walsh S, Harrington H, Walsh C (2004). "Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series". J Neurol Neurosurg Psychiatry. 75 (4): 631–3. PMID 15026513.
- ↑ Salgia RJ, Brown K (2015). "Diagnosis and management of hereditary hemochromatosis". Clin Liver Dis. 19 (1): 187–98. doi:10.1016/j.cld.2014.09.011. PMID 25454304.
- ↑ Gibbons RJ (2012). "α-Thalassemia, mental retardation, and myelodysplastic syndrome". Cold Spring Harb Perspect Med. 2 (10). doi:10.1101/cshperspect.a011759. PMC 3475406. PMID 23028133.
- ↑ Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH (2006). "Screening and counseling for thalassemia". Blood. 107 (4): 1735–7. doi:10.1182/blood-2005-09-3557. PMC 1895412. PMID 16461765.
- ↑ Ceni E, Mello T, Galli A (2014). "Pathogenesis of alcoholic liver disease: role of oxidative metabolism". World J. Gastroenterol. 20 (47): 17756–72. doi:10.3748/wjg.v20.i47.17756. PMC 4273126. PMID 25548474.
- ↑ Mathurin P, Bataller R (2015). "Trends in the management and burden of alcoholic liver disease". J. Hepatol. 62 (1 Suppl): S38–46. doi:10.1016/j.jhep.2015.03.006. PMC 5013530. PMID 25920088.
- ↑ Lucey MR, Mathurin P, Morgan TR (2009). "Alcoholic hepatitis". N. Engl. J. Med. 360 (26): 2758–69. doi:10.1056/NEJMra0805786. PMID 19553649.
- ↑ Datz C, Müller E, Aigner E (June 2017). "Iron overload and non-alcoholic fatty liver disease". Minerva Endocrinol. 42 (2): 173–183. doi:10.23736/S0391-1977.16.02565-7. PMID 27834478.
- ↑ Cazzola M, Invernizzi R (June 2011). "Ring sideroblasts and sideroblastic anemias". Haematologica. 96 (6): 789–92. doi:10.3324/haematol.2011.044628. PMC 3105636. PMID 21632840.
- ↑ Bottomley SS, Fleming MD (August 2014). "Sideroblastic anemia: diagnosis and management". Hematol. Oncol. Clin. North Am. 28 (4): 653–70, v. doi:10.1016/j.hoc.2014.04.008. PMID 25064706.
- ↑ Long Z, Li H, Du Y, Han B (August 2018). "Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology". Gene. 668: 182–189. doi:10.1016/j.gene.2018.05.074. PMID 29787825.
- ↑ Gordeuk VR (October 2002). "African iron overload". Semin. Hematol. 39 (4): 263–9. PMID 12382201.
- ↑ Gordeuk V, Caleffi A, Corradini E, Ferrara F, Jones R, Castro O, Onyekwere O, Kittles R, Pignatti E, Montosi G, Garuti C, Gangaidzo I, Gomo Z, Moyo V, Rouault T, MacPhail P, Pietrangelo A (2003). "Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene". Blood Cells Mol Dis. 31 (3): 299–304. PMID 14636642.